Detalles de la búsqueda
1.
Patient-derived tumor organoids predict responses to irinotecan-based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Int J Cancer
; 152(3): 524-535, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161653
2.
Utility of Circulating Free DNA Fragmentomics in the Prediction of Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Clin Chem
; 69(1): 88-99, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36308331
3.
Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH).
BMC Cancer
; 22(1): 274, 2022 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35291966
4.
A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRacing study.
BMC Cancer
; 22(1): 710, 2022 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35764956
5.
Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
PLoS Med
; 18(8): e1003741, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34464382
6.
A low cost and input tailing method of quality control on multiple annealing, and looping-based amplification cycles-based whole-genome amplification products.
J Clin Lab Anal
; 33(3): e22697, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30461059
7.
The predictive value of LGR for distant metastasis-free survival in locally advanced rectal cancer patients.
Heliyon
; 10(11): e32045, 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38867999
8.
Radiomics of skeletal muscle helps to predict gastrointestinal toxicity in locally advanced rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Clin Transl Radiat Oncol
; 44: 100703, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38073716
9.
Low-dose radiotherapy synergizes with iRGD-antiCD3-modified T cells by facilitating T cell infiltration.
Radiother Oncol
; 194: 110213, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38458258
10.
Radiomic score for lung nodules as a prognostic biomarker in locally advanced rectal cancer patients: A bi-institutional study.
Cancer Med
; 13(12): e7240, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38923236
11.
Study protocol of short-course radiotherapy combined with CAPOX and PD-1 inhibitor for locally advanced colon cancer: a randomised, prospective, multicentre, phase II trial (TORCH-C).
BMJ Open
; 14(2): e079442, 2024 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309748
12.
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH).
J Clin Oncol
; : JCO2302261, 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38950321
13.
The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection.
Cancer Med
; 12(8): 9482-9495, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36825605
14.
Advanced gastric cancer achieving major pathologic regression after chemoimmunotherapy combined with hypofractionated radiotherapy: A case report.
World J Gastrointest Oncol
; 15(6): 1096-1104, 2023 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37389115
15.
Newly developed 3D in vitro models to study tumor-immune interaction.
J Exp Clin Cancer Res
; 42(1): 81, 2023 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37016422
16.
Regorafenib alone or in combination with high/low-dose radiotherapy plus toripalimab as third-line treatment in patients with metastatic colorectal cancer: protocol for a prospective, randomized, controlled phase II clinical trial (SLOT).
Front Oncol
; 13: 1274487, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37869085
17.
TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial.
Front Oncol
; 13: 1304767, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38053659
18.
Long-term outcomes in a retrospective cohort of patients with rectal cancer with complete response after total neoadjuvant therapy: a propensity-score weighted analysis.
Ther Adv Med Oncol
; 15: 17588359231197955, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37701810
19.
Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E).
BMJ Open
; 13(10): e076048, 2023 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37802608
20.
RIFLE: a Phase II trial of stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer.
Gastroenterol Rep (Oxf)
; 11: goad063, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37842200